Moderna, Inc. and Catalent, Inc. expanded their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in Moderna’s pipeline, at Catalent’s biologics facility in Bloomington, IN.   Last June the companies entered an agreement for Catalent to provide aseptic vial filling and packaging from its Bloomington site, including additional staffing required for 24×7 manufacturing to s...